Scientific Digital Imaging sees revenue and earnings rise in final results
Scientific and technology products company Scientific Digital Imaging posted its final audited results for the year ended 30 April on Friday, with revenue rising to £8.5m from £7.0m a year earlier.
FTSE AIM All-Share
729.29
16:50 13/11/24
Health Care Equipment & Services
10,240.67
17:14 13/11/24
SDI Group
60.50p
16:55 13/11/24
The AIM-traded firm reported an increased gross margin of 61.1%, against 59.2%, and an operating profit £536,000 - well above 2015’s £59,000 figure.
Adjusted operating profit was £792,000 before costs of reorganisation, acquisition costs, amortisation of acquired intangibles and share based payments, almost double last year’s £420,000.
Scientific Digital Imaging’s basic earnings per share totalled 1.17p, against 0.15p.
During the year, the company completed a successful £2.5m equity fundraising enabled it to make an earnings enhancing acquisition of Sentek Limited
The board also reported Atik sales and profitability as exceeding budget
"During the year SDI has seen continued growth in its Synbiosis and Synoptics Health brands alongside high levels of growth in Artemis CCD,” said chairman Ken Ford.
“Together with the acquisition of Sentek, these have been the major contributors to the group's improved profitability.
“As well as investing in its current operations, SDI will continue to assess new businesses with complementary products and plans to add further new companies to the group,” Ford added.